(Q43288117)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

chronic myeloid leukemia

0 references

0 references

0 references

1 reference

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Carolina Pavlovsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Merrill J Egorin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Dhvani D Shah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Silvia Rogel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Santiago Pavlovsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

1 September 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

1152-1156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

6 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Clinical pharmacokinetics of imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Low plasma level of all-trans retinoic acid after feeding tube administration for acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Effect of antacid on imatinib absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.9.1152

21 January 2018

Identifiers

DOI

10.1592/PHCO.29.9.1152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19698017%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference